DOD Taps Continuus for Onshore Production of Active Pharmaceutical Ingredients

DOD Taps Continuus for Onshore Production of Active Pharmaceutical Ingredients
Continuus Pharmaceuticals

Continuus Pharmaceuticals has secured a $69.3M contract with the Department of Defense to use its integrated continuous manufacturing technology for developing critical active pharmaceutical ingredients and final dosage form medicines used for COVID-19 treatment.

The company will employ the ICM, a fully-automated, small-footprint facility, to provide the U.S. with domestic production capability in support of caring for COVID-19 patients, DOD said Friday.

The U.S. currently sources critical APIs and their starting materials from companies outside the country.

With the investment, Continuus will enable onshore manufacturing of three critical APIs and their final dosage forms. The company will also use the ICM technology to streamline logistical processes for future health care needs.

DOD issued the contract in coordination with the Department of Health and Human Services and under the Coronavirus Aid, Relief, and Economic Security Act.

You may also be interested in...

Anitian

Anitian, Microsoft Partnership Adds Compliance Automation Tech to Azure

Anitian and Microsoft have lenabled the former's automation tool to help customers deploy workloads into the Azure cloud environment and speed up cloud migration processes.

Machine learning framework

DARPA Taps University of Massachusetts, Amherst for Machine Learning Framework Development

A University of Massachusetts, Amherst laboratory has received a contract fom the Defense Advanced Research Projects Agency to design a framework for machine learning in support of the Ditto - Intelligent Auto-Generation and Composition of Surrogate Models project.

William Irby COO Martin UAV

William Irby Named Martin UAV COO, Sean Olds Appointed CFO

William Irby, a nearly three-decade aerospace and defense industry veteran, has joined unmanned aircraft system manufacturing company Martin UAV as chief operating officer.